The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market was valued at US$ 11200 million in 2023 and is anticipated to reach US$ 18170 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market

The Dipeptidyl Peptidase IV (DPP-IV) inhibitors market refers to the industry that focuses on the production and distribution of medications known as DPP-IV inhibitors. DPP-IV inhibitors are a class of oral antidiabetic drugs used in the treatment of type 2 diabetes mellitus. They work by inhibiting the action of the enzyme DPP-IV, which leads to increased levels of incretin hormones and improved glycemic control.

The DPP-IV inhibitors market is a segment within the broader pharmaceutical industry, specifically in the field of diabetes management. It involves the development, manufacturing, and distribution of DPP-IV inhibitor medications used to treat type 2 diabetes.

The DPP-IV inhibitors market is influenced by factors such as the increasing prevalence of type 2 diabetes worldwide, the rising demand for effective oral antidiabetic medications, and the growing emphasis on diabetes management and control. Additionally, factors such as an aging population, sedentary lifestyles, and changes in dietary habits contribute to the market's growth.

This report aims to provide a comprehensive presentation of the global market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dipeptidyl Peptidase IV (DPP-IV) Inhibitors.

Report Scope

The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report

Report Metric	Details
Report Name	Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
Accounted market size in 2023	US$ 11200 million
Forecasted market size in 2030	US$ 18170 million
CAGR	7.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Sitagliptin Vildagliptin Saxagliptin Linagliptin Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca, Boehringer, Eli Lilly, Merck, Mitsubishi Tanabe Pharma, Novartis, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market growing?

Ans: The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market witnessing a CAGR of 7.1% during the forecast period 2024-2030.

What is the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market size in 2030?

Ans: The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market size in 2030 will be US$ 18170 million.

Who are the main players in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market report?

Ans: The main players in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market are AstraZeneca, Boehringer, Eli Lilly, Merck, Mitsubishi Tanabe Pharma, Novartis, Takeda

What are the Application segmentation covered in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market report?

Ans: The Applications covered in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market report?

Ans: The Types covered in the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market report are Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Others

1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Overview

1.1 Product Overview and Scope of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors

1.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Type

1.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Type (2024-2030)

1.2.2 Sitagliptin

1.2.3 Vildagliptin

1.2.4 Saxagliptin

1.2.5 Linagliptin

1.2.6 Others

1.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Application

1.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Estimates and Forecasts

1.4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue 2019-2030

1.4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales 2019-2030

1.4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competition by Manufacturers

2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2019-2024)

2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price by Manufacturers (2019-2024)

2.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Product Type & Application

2.7 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Situation and Trends

2.7.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players Market Share by Revenue

2.7.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Retrospective Market Scenario by Region

3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2019-2030

3.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2019-2024

3.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2025-2030

3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2019-2030

3.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2019-2024

3.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2025-2030

3.4 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country

3.4.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2030)

3.4.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country

3.5.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2030)

3.5.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country

3.6.1 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2030)

3.6.3 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country

3.7.1 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2030)

3.7.3 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2030)

3.8.3 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2019-2030)

4.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2019-2024)

4.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2025-2030)

4.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2019-2030)

4.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2019-2024)

4.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2025-2030)

4.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2019-2030)

5 Segment by Application

5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2019-2030)

5.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2019-2024)

5.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2025-2030)

5.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2019-2030)

5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2019-2030)

5.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2019-2024)

5.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2025-2030)

5.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2019-2030)

5.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Corporation Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Boehringer

6.2.1 Boehringer Corporation Information

6.2.2 Boehringer Description and Business Overview

6.2.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.2.5 Boehringer Recent Developments/Updates

6.3 Eli Lilly

6.3.1 Eli Lilly Corporation Information

6.3.2 Eli Lilly Description and Business Overview

6.3.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.3.5 Eli Lilly Recent Developments/Updates

6.4 Merck

6.4.1 Merck Corporation Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Mitsubishi Tanabe Pharma

6.5.1 Mitsubishi Tanabe Pharma Corporation Information

6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.5.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.6 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.6.5 Novartis Recent Developments/Updates

6.7 Takeda

6.6.1 Takeda Corporation Information

6.6.2 Takeda Description and Business Overview

6.6.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio

6.7.5 Takeda Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Chain Analysis

7.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process

7.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Marketing

7.4.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Channels

7.4.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors

7.5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers

8 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Dynamics

8.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends

8.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers

8.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges

8.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

Novartis

Takeda

List of Tables

Table 1. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Situation by Manufacturers in 2023

Table 4. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) of Key Manufacturers (2019-2024)

Table 5. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2019-2024) & (K MT)

Table 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2019-2024)

Table 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2025-2030) & (K MT)

Table 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2025-2030)

Table 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2019-2024)

Table 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2025-2030)

Table 25. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2024) & (K MT)

Table 27. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2025-2030) & (K MT)

Table 28. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2024) & (K MT)

Table 32. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2025-2030) & (K MT)

Table 33. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2019-2024) & (K MT)

Table 37. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2025-2030) & (K MT)

Table 38. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2024) & (K MT)

Table 42. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2025-2030) & (K MT)

Table 43. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2019-2024) & (K MT)

Table 47. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2025-2030) & (K MT)

Table 48. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2019-2024)

Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2025-2030)

Table 52. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2019-2024)

Table 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2025-2030)

Table 54. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2019-2024)

Table 57. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2025-2030)

Table 58. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Type (2019-2024)

Table 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Type (2025-2030)

Table 60. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Application (2019-2024)

Table 61. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Application (2025-2030)

Table 62. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2019-2024)

Table 63. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2025-2030)

Table 64. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2019-2024)

Table 67. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2025-2030)

Table 68. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Application (2019-2024)

Table 69. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Application (2025-2030)

Table 70. AstraZeneca Corporation Information

Table 71. AstraZeneca Description and Business Overview

Table 72. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 74. AstraZeneca Recent Developments/Updates

Table 75. Boehringer Corporation Information

Table 76. Boehringer Description and Business Overview

Table 77. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 79. Boehringer Recent Developments/Updates

Table 80. Eli Lilly Corporation Information

Table 81. Eli Lilly Description and Business Overview

Table 82. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 84. Eli Lilly Recent Developments/Updates

Table 85. Merck Corporation Information

Table 86. Merck Description and Business Overview

Table 87. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 89. Merck Recent Developments/Updates

Table 90. Mitsubishi Tanabe Pharma Corporation Information

Table 91. Mitsubishi Tanabe Pharma Description and Business Overview

Table 92. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates

Table 95. Novartis Corporation Information

Table 96. Novartis Description and Business Overview

Table 97. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 99. Novartis Recent Developments/Updates

Table 100. Takeda Corporation Information

Table 101. Takeda Description and Business Overview

Table 102. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product

Table 104. Takeda Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List

Table 108. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers List

Table 109. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends

Table 110. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers

Table 111. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges

Table 112. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors

Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Type in 2023 & 2030

Figure 4. Sitagliptin Product Picture

Figure 5. Vildagliptin Product Picture

Figure 6. Saxagliptin Product Picture

Figure 7. Linagliptin Product Picture

Figure 8. Others Product Picture

Figure 9. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Application in 2023 & 2030

Figure 11. Hospital Pharmacies

Figure 12. Retail Pharmacies

Figure 13. Online Pharmacies

Figure 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size (2019-2030) & (US$ Million)

Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2019-2030) & (K MT)

Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price (USD/MT) & (2019-2030)

Figure 18. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Report Years Considered

Figure 19. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Manufacturers in 2023

Figure 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players: Market Share by Revenue in 2023

Figure 22. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2019-2030)

Figure 25. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2019-2030)

Figure 29. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 30. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2019-2030)

Figure 37. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2019-2030)

Figure 48. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type (2019-2030)

Figure 58. Global Revenue Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type (2019-2030)

Figure 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Type (2019-2030)

Figure 60. Global Sales Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application (2019-2030)

Figure 61. Global Revenue Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application (2019-2030)

Figure 62. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Application (2019-2030)

Figure 63. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain

Figure 64. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions